Session Details

F119 Fractional Laser and Light-based Technologies

Mon, Mar 11, 3:30 PM - 5:30 PM
Room 6C
2 CME Available Forum
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This session is appropriate for experienced and potential users of fractional laser and light technologies. Specific treatment protocols will be outlined and tips to optimize clinical outcomes will be shared. The expert faculty will use evidence-based approaches to examine the strengths and weaknesses of current fractional technology. A review of fractionated laser skin resurfacing and rejuvenation in varying skin tones and conditions as well as a discussion of future technologic applications will provide the attendee with the latest advancements in the fields.

LEARNING OBJECTIVES

1.

Discuss the current indications, limitations, and potential for fractional laser, light-based and energy-based devices in dermatology.

2.

Identify possible side effects and complications of fractionated skin resurfacing and rejuvenation procedures and develop strategies to prevent and treat them.

3.

Identify where fully ablative resurfacing would be preferable to fractional resurfacing.

SCHEDULE

10:30 PM

Introduction

Roy G. Geronemus, MD, FAAD

10:35 PM

Fractional Lasers Overview

Roy G. Geronemus, MD, FAAD

10:55 PM

Laser Scar Revision: Fractional Technology and Combination Treatment

Jill S. Waibel, MD, FAAD

11:15 PM

Fractional Resurfacing in Skin of Color

Douglas Wu, MD, PhD, FAAD

11:35 PM

Non Laser Fractional Resurfacing and Rejuvenation

Jordan Victor Wang, MD, MBE, MBA, FAAD

11:55 PM

The Role of Non Fractional Lasers

Joel Lee Cohen, MD, FAAD

12:15 AM

Questions and Answers

SPEAKERS

Joel Lee Cohen, MD, FAAD

Joel Lee Cohen, MD, FAAD

Roy G. Geronemus, MD, FAAD

Roy G. Geronemus, MD, FAAD

Jill S. Waibel, MD, FAAD

Jill S. Waibel, MD, FAAD

Jordan Victor Wang, MD, MBE, MBA, FAAD

Jordan Victor Wang, MD, MBE, MBA, FAAD

Douglas Wu, MD, PhD, FAAD

Douglas Wu, MD, PhD, FAAD

HANDOUTS

Login to view handouts

SPEAKER DISCLOSURES

Joel Lee Cohen, MD, FAAD

Accure Medical, LLC – Investigator(Stock Options); Allergan, Inc. – Consultant(Honoraria); Brickell Biotech, Inc. – Investigator(Grants/Research Funding); BTL Industries – Investigator(Grants/Research Funding); Ferndale Laboratories, Inc. – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria), Investigator(Grants/Research Funding); Merz Pharmaceuticals, LLC – Consultant(Honoraria); Pulse Biosciences – Investigator(Grants/Research Funding); Revance Therapeutics, Inc. – Investigator(Grants/Research Funding); Sciton Inc. – Consultant(Honoraria);

Roy G. Geronemus, MD, FAAD

Allergan, Inc – Investigator(Grants/Research Funding); Allergan, Inc. – Advisory Board(Grants/Research Funding); ArchiMedus – Investigator(Grants/Research Funding); Candela Corporation – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Cynosure, Inc – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Advisory Board(Grants/Research Funding), Investigator(Stock), Stockholder(Stock); Lutronic – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding); Merz Aesthetics – Investigator(Grants/Research Funding); New York Stem Cell Foundation – Investigator(Grants/Research Funding); Syneron Candela – Advisory Board(Grants/Research Funding), Investigator(Grants/Research Funding);

Jill S. Waibel, MD, FAAD

Allergan – Consultant (1099 relationship)(Honoraria); Amgen – Investigator(Grants/Research Funding); argenx – Investigator(Grants/Research Funding); Bristol-Myers Squibb – Investigator(Grants/Research Funding); Candela Corporation – Consultant (1099 relationship)(Honoraria); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Galderma – Investigator(Grants/Research Funding); Horizon Pharma, Inc. – Investigator(Grants/Research Funding); Pfizer Inc. – Investigator(Grants/Research Funding); Procter & Gamble Company – Consultant (1099 relationship)(Honoraria); Regenx – Advisory Board(No Compensation Received), Investigator(Grants/Research Funding); Sanofi – Investigator(Grants/Research Funding); Shanghai Fudan-Zhangjiang Bio Pharmaceutical Co., Ltd. – Investigator(Grants/Research Funding); SkinCeuticals LLC – Investigator(Grants/Research Funding); VA Merit Grant – Other(No Compensation Received);

Jordan Victor Wang, MD, MBE, MBA, FAAD

Accure, Inc – Investigator(Grants/Research Funding); Alastin Skincare, Inc – Investigator(Grants/Research Funding); Allergan Aesthetics – Investigator(Grants/Research Funding); AVAVA, LLC – Investigator(Grants/Research Funding); Blossom Innovations, LLC – Investigator(Grants/Research Funding); Cynosure – Investigator(Grants/Research Funding); Cytrellis Biosystems, Inc – Investigator(Grants/Research Funding); Lutronic – Investigator(Grants/Research Funding); Novoxel – Investigator(Grants/Research Funding); Sofwave – Investigator(Grants/Research Funding); Soliton – Investigator(Grants/Research Funding); Solta Medical – Investigator(Grants/Research Funding);

Douglas Wu, MD, PhD, FAAD

Allergan, Inc. – Speaker/Faculty Education(Honoraria); Galderma USA – Speaker/Faculty Education(Honoraria); Syneron Candela – Consultant(Honoraria);